INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 211 filers reported holding INTRA CELLULAR THERAPIES INC in Q4 2021. The put-call ratio across all filers is 0.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $46,099,650 | +51.7% | 885,000 | +84.4% | 0.10% | +59.1% |
| Q2 2023 | $30,393,600 | +53.8% | 480,000 | +31.5% | 0.07% | +50.0% |
| Q1 2023 | $19,764,750 | +39.3% | 365,000 | +19.7% | 0.04% | +25.7% |
| Q3 2022 | $14,192,000 | -75.2% | 305,000 | -69.6% | 0.04% | -73.3% |
| Q2 2022 | $57,267,000 | +10.1% | 1,003,271 | +18.0% | 0.13% | +32.3% |
| Q1 2022 | $52,012,000 | +297.5% | 850,000 | +240.0% | 0.10% | +312.5% |
| Q4 2021 | $13,085,000 | +17.0% | 250,000 | -16.7% | 0.02% | +9.1% |
| Q3 2021 | $11,184,000 | -54.3% | 300,000 | -50.0% | 0.02% | -54.2% |
| Q2 2021 | $24,492,000 | -9.8% | 600,000 | -25.0% | 0.05% | -12.7% |
| Q1 2021 | $27,144,000 | +12.0% | 800,000 | +4.9% | 0.06% | +3.8% |
| Q4 2020 | $24,245,000 | +136.2% | 762,417 | +90.6% | 0.05% | +103.8% |
| Q3 2020 | $10,264,000 | +12.2% | 400,000 | -33.3% | 0.03% | +4.0% |
| Q3 2016 | $9,144,000 | -78.6% | 600,000 | -45.5% | 0.02% | -78.6% |
| Q2 2016 | $42,702,000 | +39.6% | 1,100,000 | 0.0% | 0.12% | +41.0% |
| Q1 2016 | $30,580,000 | -47.2% | 1,100,000 | +2.2% | 0.08% | -45.4% |
| Q4 2015 | $57,903,000 | +26.2% | 1,076,462 | -6.0% | 0.15% | +19.7% |
| Q3 2015 | $45,876,000 | +105.1% | 1,145,766 | +63.7% | 0.13% | +126.8% |
| Q2 2015 | $22,365,000 | +33.8% | 700,000 | 0.0% | 0.06% | +36.6% |
| Q1 2015 | $16,716,000 | +18.4% | 700,000 | -12.5% | 0.04% | +17.1% |
| Q4 2014 | $14,120,000 | +37.3% | 800,000 | +6.7% | 0.04% | +40.0% |
| Q3 2014 | $10,283,000 | +35.5% | 750,000 | +66.7% | 0.02% | +25.0% |
| Q2 2014 | $7,587,000 | +4.3% | 450,000 | +12.5% | 0.02% | 0.0% |
| Q1 2014 | $7,272,000 | – | 400,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 175,000 | $9,115,750 | 10.70% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 317,856 | $16,547,583 | 5.57% |
| Deep Track Capital, LP | 2,600,000 | $135,434,000 | 5.23% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,369,849 | $71,355,434 | 3.86% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 208,730 | $10,872,746 | 3.30% |
| DCF Advisers, LLC | 107,157 | $5,581,808 | 3.04% |
| Bellevue Group AG | 3,170,250 | $165,138,323 | 2.66% |
| Vahanian & Associates Financial Planning Inc. | 15,217 | $792,654 | 2.55% |
| Iron Triangle Partners LP | 330,549 | $17,218,297 | 2.52% |
| TANG CAPITAL MANAGEMENT LLC | 300,000 | $15,627,000 | 2.20% |